Jonathan D. Ashley, Ph.D. - Publications

Affiliations: 
2014 Chemical and Biomolecular Engineering University of Notre Dame, Notre Dame, IN, United States 
Area:
Biomedical Engineering, Nanoscience

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Stefanick JF, Omstead DT, Ashley JD, Deak PE, Mustafaoglu N, Kiziltepe T, Bilgicer B. Optimizing design parameters of a peptide targeted liposomal nanoparticle in an in vivo multiple myeloma disease model after initial evaluation in vitro. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31473250 DOI: 10.1016/J.Jconrel.2019.08.033  0.626
2016 Ashley JD, Quinlan CJ, Schroeder VA, Suckow MA, Pizzuti VJ, Kiziltepe T, Bilgicer B. Dual Carfilzomib and Doxorubicin Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple Myeloma. Molecular Cancer Therapeutics. PMID 27196779 DOI: 10.1158/1535-7163.Mct-15-0867  0.483
2014 Ashley JD, Stefanick JF, Schroeder VA, Suckow MA, Alves NJ, Suzuki R, Kikuchi S, Hideshima T, Anderson KC, Kiziltepe T, Bilgicer B. Liposomal carfilzomib nanoparticles effectively target multiple myeloma cells and demonstrate enhanced efficacy in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society. 196: 113-21. PMID 25312543 DOI: 10.1016/J.Jconrel.2014.10.005  0.526
2014 Ashley JD, Stefanick JF, Schroeder VA, Suckow MA, Kiziltepe T, Bilgicer B. Liposomal bortezomib nanoparticles via boronic ester prodrug formulation for improved therapeutic efficacy in vivo. Journal of Medicinal Chemistry. 57: 5282-92. PMID 24897555 DOI: 10.1021/Jm500352V  0.481
2014 Noble GT, Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B. Ligand-targeted liposome design: challenges and fundamental considerations. Trends in Biotechnology. 32: 32-45. PMID 24210498 DOI: 10.1016/J.Tibtech.2013.09.007  0.478
2014 Stefanick J, Ashley J, Kiziltepe T, Bilgicer B. Abstract 5376: Systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomal nanoparticles Cancer Research. 74: 5376-5376. DOI: 10.1158/1538-7445.Am2014-5376  0.574
2013 Stefanick JF, Ashley JD, Bilgicer B. Enhanced cellular uptake of peptide-targeted nanoparticles through increased peptide hydrophilicity and optimized ethylene glycol peptide-linker length. Acs Nano. 7: 8115-27. PMID 24003770 DOI: 10.1021/Nn4033954  0.533
2013 Alves NJ, Cusick W, Stefanick JF, Ashley JD, Handlogten MW, Bilgicer B. Functionalized liposome purification via Liposome Extruder Purification (LEP). The Analyst. 138: 4746-51. PMID 23841107 DOI: 10.1039/C3An00680H  0.619
2013 Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B. A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. Acs Nano. 7: 2935-47. PMID 23421406 DOI: 10.1021/Nn305663E  0.547
2013 Kiziltepe T, Ashley J, Stefanick J, Bilgicer B. Abstract 4524: Designer nanoparticles for selective targeting of multiple myeloma and overcoming CAM-DR. Cancer Research. 73: 4524-4524. DOI: 10.1158/1538-7445.Am2013-4524  0.588
2013 Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B. A systematic analysis of peptide linker length and polyethylene glycol coating on cellular uptake of peptide-targeted liposomes Pharmaceutical Discovery, Development and Manufacturing Forum 2013 - Core Programming Area At the 2013 Aiche Annual Meeting: Global Challenges For Engineering a Sustainable Future. 221-222.  0.336
2012 Alves NJ, Stimple SD, Handlogten MW, Ashley JD, Kiziltepe T, Bilgicer B. Small-molecule-based affinity chromatography method for antibody purification via nucleotide binding site targeting. Analytical Chemistry. 84: 7721-8. PMID 22928545 DOI: 10.1021/Ac300952R  0.599
2012 Kiziltepe T, Ashley JD, Stefanick JF, Qi YM, Alves NJ, Handlogten MW, Suckow MA, Navari RM, Bilgicer B. Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo. Blood Cancer Journal. 2: e64. PMID 22829966 DOI: 10.1038/Bcj.2012.10  0.664
2012 Kiziltepe T, Ashley JD, Stefanick JF, Alves NJ, Handlogten MW, Qi YM, Suckow M, Navari R, Bilgicer B. Abstract 5686: Engineering multifunctional nanoparticles to selectively target multiple myeloma cells and overcome cell adhesion-mediated drug resistance Cancer Research. 72: 5686-5686. DOI: 10.1158/1538-7445.Am2012-5686  0.581
2011 Bilgicer B, Kiziltepe T, Ashley J, Qi YM, Stefanick J. Abstract 3636: Enhancement of trastuzumab selectivity via cyclic complex formation Cancer Research. 71: 3636-3636. DOI: 10.1158/1538-7445.Am2011-3636  0.43
Show low-probability matches.